Patent Notice. Licensee shall place in a conspicuous location on Licensed Products patent notice in accordance with 35 U.S.C. §287 and in accordance with the applicable laws in each jurisdiction of the Licensed Territory in which the Licensed Products are made, used, sold, offered for sale or Otherwise Disposed Of. Licensee agrees to xxxx any Licensed Products with the word “patent” or “xxx.” and the number of each applicable licensed patent hereunder, and, with respect to such licensed patents, to respond to any request for disclosure under 35 U.S.C. §287(b)(4)(B) by only notifying Licensor of the request for disclosure.
Patent Notice. For each sale or other transfer of TCC or Related IC Devices by Licensee, the documentation from Licensee shall include a prominent written notice Tessera Confidential that "These products are made under a license from Tessera, Inc. under Patent Numbers_________ (the then issued Tessera patents relevant to this Agreement)".
Patent Notice. For each sale or other transfer of a Licensed Product by Licensee, the documentation from Licensee shall include a prominent written notice that “These products are made under a license from Tessera, Inc.”
Patent Notice. If required, and in order to protect Company’s IP Rights, Distributor agrees, where applicable, that a valid patent notice for the Products will appear on any: (i) media for the Products and any Customer packaging materials associated therein; and (ii) Documentation and promotional material for the Products.
Patent Notice. Diomed agrees to apply, or cause to be applied, an appropriate patent notice on all Products manufactured or sold by Diomed, its affiliates, subsidiaries or sublicensees hereunder and to accept the reasonable suggestions of QLT with respect thereto.
Patent Notice. Siemens shall xxxx each Licensed Real-Time Thermal Cycler and include prominently in the front of the corresponding user’s manual, but not any other Thermal Cycler or manual therefor, a Notice to User as follows:
Patent Notice. Licensee agrees to xxxx or cause its applicable Affiliate to xxxx each Licensed Product and include prominently in the corresponding user’s manual, but not any other Thermal Cycler or manual therefor, a Notice to purchaser as specified from time to time by Licensor. Unless and until Licensor instructs differently (upon which instruction Licensee will implement the new Notice within a commercially reasonable timeframe not to exceed one hundred eighty (180) days after Licensee’s receipt of such instruction), the Notice shall be: * Confidential Treatment Requested by Celera Corporation* HIGHLY CONFIDENTIAL EXECUTION VERSION
Patent Notice. In lieu of exercising its option in accordance with Section 3.4(c), Sponsor may, in its sole discretion, elect to pay for the filing of a provisional patent application claiming or covering the Technology that is the subject of the Technology Disclosure. In the event that the Sponsor determines it will support and pay the filing of a provisional patent application, it shall send written notice to TSRI within the Option Period, that it will pay for the filing of one or more provisional patent applications in respect of such Technology (the “Patent Notice”). The parties hereby agree that TSRI shall prepare and file such provisional patent application for the Technology identified by Sponsor in the Patent Notice in accordance with Section 4.4 hereof. Sponsor shall have [***] from the date of filing a patent application in which to deliver to TSRI an Option Notice for the patent application. Upon delivery of the Option Notice pursuant to this Section 3.4(d), the parties shall have [***] in which to negotiate with reasonable diligence and in good faith to enter into a License Agreement for the patent application, which shall be materially consistent with the terms of the License Agreement set forth in Exhibit E.
Patent Notice. Customer is hereby placed on notice that the Solution, Solution updates, their related technology and services may be covered by one or more United States (“US”) and non-US patents. A listing that associates patented products included in the Solution, Solution updates, their related technology and services with one or more patent numbers is available for Customer’s and the general public’s access at: xxxxx://xxxxxxxx.xxxxxxxxxx.xx/xxx (hereinafter, the “Patent Notice”) and any successor or related locations designated by Service Provider. The association of products-to-patent numbers in the Patent Notice may not be an exclusive listing of associations, and other unlisted patents or pending patents may also be associated with the Solution. Likewise, the patents or pending patents may also be associated with unlisted products. Customer agrees to regularly review the products-to-patent number(s) association at the Patent Notice to check for updates. The Solution may include third- party products identified below and sublicensed by Service Provider to Customer. Some or all associations of the third-party products-to-patents are also identified in the Patent Notice by each associated third-party and product name.
Patent Notice. Thermal Cycler Supplier agrees to include prominently in the front of the user’s manual for each Authorized Thermal Cycler, and for no other Thermal Cycler or Temperature Cycling Instrument, a notice (“Notice”) as specified from time to time by ABI. Unless and until ABI reasonably instructs differently, the Notice shall be: Authorized Thermal Cycler Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. This instrument, Serial No. , is an Authorized Thermal Cycler. Its purchase price includes the up-front fee component of a license under United States Patent Nos. 4,683,195, 4,683,202 and 4,965,188, owned by Roche Molecular Systems, Inc., and under corresponding claims in patents outside the United States, owned by X. Xxxxxxxx-Xx Xxxxx Ltd, covering the Polymerase Chain Reaction (“PCR”) process, to practice the PCR process for internal research and development using this instrument. The running royalty component of that license may be purchased from Applied Biosystems or obtained by purchasing Authorized Reagents. This instrument is also an Authorized Thermal Cycler for use with applications licenses available from Applied Biosystems. Its use with Authorized Reagents also provides a limited PCR license in accordance with the label rights accompanying such reagents. Purchase of this product does not itself convey to the purchaser a complete license or right to perform the PCR process. Further information on purchasing licenses to practice the PCR process may be obtained by contacting the Director of Licensing at Applied Biosystems, 000 Xxxxxxx Xxxxxx Xxxxx, Xxxxxx Xxxx, Xxxxxxxxxx 00000, XXX. No rights are conveyed expressly, by implication or estoppel to any patents on real-time methods, including but not limited to 5’ nuclease assays, or to any patent claiming a reagent or kit. Applied Biosystems does not guarantee the performance of this instrument.
